Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
InnoCan Pharma Corp (CNQ:INNO)
|Dividend Rate (ttm)||0.0000|
|Trading Day||Sep 17|
|Day's Range||Market Closed|
|52 Week Range||0.15 - 1.57|
InnoCan Pharma Corp dividends
InnoCan Pharma Corp has a market cap or net worth of $287.69 million. The enterprise value is $0.
InnoCan Pharma Corp has 221.30 million shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is 0.0000. InnoCan Pharma Corp's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 3.6866%. The beta is 0.0000, so InnoCan Pharma Corp's price volatility has been lower than the market average.
In the last 12 months, InnoCan Pharma Corp had revenue of $0 and earned $0 in profits. Earnings per share was $.